Cognitive Behavioral Therapy Advised for Chronic Insomnia

Share this content:
Cognitive Behavioral Therapy Advised for Chronic Insomnia
Cognitive Behavioral Therapy Advised for Chronic Insomnia

TUESDAY, May 3, 2016 (HealthDay News) -- Cognitive behavioral therapy is recommended as the initial treatment for all adults with chronic insomnia disorder, according to a clinical practice guideline published online May 3 in the Annals of Internal Medicine.

Amir Qaseem, M.D., Ph.D., from the American College of Physicians (ACP) in Philadelphia, and colleagues conducted a systematic review of randomized controlled trials to develop recommendations on the management of chronic insomnia disorder in adults. Evaluated outcomes included questionnaire-assessed global outcomes, patient-reported sleep outcomes, and harms.

The researchers developed two recommendations for chronic insomnia disorder. All adult patients should receive cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment (Grade: strong recommendation; moderate-quality evidence). In addition, clinicians should employ a shared decision-making approach, including discussion of the benefits, harms, and costs of short-term medication use, in order to decide whether to add pharmacologic therapy for adults in whom CBT-I alone was unsuccessful (Grade: weak recommendation; low-quality evidence).

"Cognitive behavioral therapy for insomnia is an effective treatment and can be initiated in a primary care setting," ACP President Wayne J. Riley, M.D., M.P.H., said in a statement. "Although we have insufficient evidence to directly compare CBT-I and drug treatment, CBT-I is likely to have fewer harms. Sleep medications can be associated with serious adverse effects."

Clinical Practice Guideline
Evidence Review 1 (subscription or payment may be required)
Evidence Review 2 (subscription or payment may be required)
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

CDC Concerned About Falling Flu Vaccination Rates

CDC Concerned About Falling Flu Vaccination Rates

Decline among vulnerable older adults is of particular concern

One in Five With Non-Valvular A-Fib Receiving Digoxin

One in Five With Non-Valvular A-Fib Receiving Digoxin

Indication for digoxin use was considered inappropriate in 59.8 percent in Turkish cohort

Rapid, Successful Response to ART for Many Patients With HIV

Rapid, Successful Response to ART for Many Patients ...

Factors associated with virological success include having undetectable viral load, use of three drugs

is free, fast, and customized just for you!

Already a member?

Sign In Now »